In February this year, EILF kicked off Phase 1 of the EILF NAFLD Policy Review. This first of its kind research project aims to establish to what extent governments and key stakeholders like medical associations and patient groups are responding to the major public health threat that is non-alcoholic fatty liver disease (NAFLD)/ non-alcoholic steatohepatitis (NASH), raise awareness of the conditions and inform on the need for further initiatives and areas for collaboration. Phase 1 saw the review completed in 8 countries and the preliminary results showcased in a briefing chaired by Prof. Jeffrey Lazarus, and Prof. Quentin Anstee at the EASL International Liver Congress in April. Whilst the results are being written up for publication, Phase 2 will launch, seeing the review expanded to the remaining EU-28 countries.

 

 

Data Protection and Privacy Policy

EASL International Liver Foundation

We take the protection of your personal data seriously, meaning that we process your personal data with due care and in accordance with applicable data protection laws.

Consent

Please note that by clicking the box “I agree”, you explicitly agree to the processing of your personal data for the purposes and pursuant to the terms and conditions mentioned in our Data Protection and Privacy Policy available at here“.

Contact

For any question or request, please contact us at EASL International Live Foundation, Rue Daubin 7, 1203 Geneva, Switzerland, telephone 0041 (0)22 552 2497 gdpr@easl-ilf.org